CAPRICOR THERAPEUTICS, INC. Marketable Securities (Current)
CAPRICOR THERAPEUTICS, INC. (CAPR) had Marketable Securities (Current) of $79.06 million as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-11-10
- 2025-09-30: Marketable Securities, Current $79.06M.
- 2025-06-30: Marketable Securities, Current $99.56M.
- 2025-03-31: Marketable Securities, Current $115.98M.
- 2024-12-31: Marketable Securities, Current $140.23M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-09-30 | $79.06M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $99.56M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $115.98M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $140.23M 10-Q · filed 2025-11-10 |
| 2024-09-30 | $16.65M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $18.77M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $33.70M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $24.79M 10-K · filed 2025-03-26 |
| 2023-09-30 | $19.54M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $27.96M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $34.57M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $31.82M 10-K · filed 2024-03-11 |
| 2022-09-30 | $38.20M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $35.02M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-17 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-12-31 | $5.99M 10-K · filed 2021-03-15 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 |
| 2018-12-31 | $3.00M 10-K · filed 2020-03-27 |
| 2018-09-30 | $5.99M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $6.00M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $6.00M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $7.98M 10-K · filed 2019-03-29 |
| 2017-09-30 | $5.00M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.00M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $8.99M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $12.99M 10-K · filed 2018-03-22 |
| 2016-09-30 | $2.50M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.50M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $2.50M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $8.00M 10-K · filed 2017-03-16 |
| 2015-09-30 | $13.00M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $15.49M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $15.48M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2014-09-30 | $325.32K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $325.79K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $326.23K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $326.49K 10-K · filed 2015-03-16 |
| 2012-12-31 | $4.19M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |